Member Info for Chickenlicken1

cant remember the rules exactly as its so long since i read them...10 years+. Disclosure of trades can be delayed if the number exceeds the normal market size NMS by a significant margin. the extent of the delay depends upon the size of the trade. there is more to it but i simply dont remember.

definitely not

can only assume that this has been tipped somewhere

i think that the management should have bitten the bullet and raised a bit more cash when issuing the results rather than declaring their intention in the notes to the accounts. they need to announce an uplift from the chinese launch to improve sentiment. for the time being the price will be nailed down by uncertainty. the risks of illiquidity fully evident here. i still believe that the company has good potential but will delay adding until they've raised some more cash. the overhead reduction probably reduces the breakeven level of earnings quite a bit.

eagerly awaited and i think worth the wait. margins up, revenues up, cost control and some jam for tomorrow. Was hoping for profitability but it's within a whisker. the half yearly results should hopefully consolidate the story as there should be some news on the JV. A good decision to cut loose the tyre recycling albatross.

Am going to stick my neck out and say these shares should be going up. Fx is causing issues for those with em earnings but SYM does all transactions in USD. UAE has ramped up beneficial legislation. CEO also revealed record orders from plastic conf (how much have they sold there previously?!). Conscious that no trading update forthcoming at date of last year's. They do have form on this from the past. J&j deal a big endorsement with revenues in 2014. However, experience has taught me to count those chickens when revenues actually appear. Cash is tight but inv financing provides headroom.

please correct me if you think i'm wrong but the fall here seems out of all proportion to any concern about the earnings shortfall and EM exposure. The US provides a large slug of revenue through pools biz which is back on track. Sales in China are rising and the $500k stand still payment is a precursor to a market launch for which product is being shipped. The volumes are tiny and anyone who is cutting their losses and running is getting clobbered on the price. I also believe that the Renminbi is more likely to rise rel to USD than fall. This would amplify increasing chinese sales.

Todays announcement is quite significant. If it can extract mutations from blood it bypasses a time consuming and more costly lab process it has genuine value. Was hoping for a trading update though.

if you are interested in water for Fracking Halosource recently signed a deal to treat water from US wells. Tiny part of revenues though. the shares are somewhat cheaper than they were at the beginning of the week...

I first heard about Halosource from Tom Bulford when it was trading at around 140p. it was an excellent story so i put it on my watchlist and forgot about it. Surely their sell rec is more about maintaining some sort of credibility. I'm more inclined to buy at these levels. it's not an appropriate share for those who dont have the patience to wait and a tolerance for volatility. To my mind the co is finally starting to fulfill its potential!